AGP Executive Report
Last update: a day agoCancer Care Update: The phase 3 SENOMAC trial at ASCO reports that for breast cancer patients with macrometastases, omitting axillary lymph node dissection (ALND) delivered non-inferior survival and significantly fewer arm-related complications than completing ALND. Oncology Drug Strategy: ASCO also highlighted the phase 3 frontMIND trial: adding tafasitamab plus lenalidomide to R-CHOP reduced progression or death risk in newly diagnosed high-risk DLBCL/HGBL versus R-CHOP alone, with investigators calling it a potential new frontline standard. Infectious Disease Watch: WHO chief visits Bunia in eastern Congo as Ebola cases rise; WHO reports 134 confirmed cases and 18 deaths in DRC and Uganda, while Kenya’s court temporarily suspends a proposed Ebola quarantine facility plan for foreigners. Public Health & Safety: Germany’s foreign ministry voiced concern over Israel’s reported plans to expand control in Gaza, warning it could complicate humanitarian aid delivery to civilians and health services. Health-Related Mobility: A two-vehicle crash in Montgomery County sent five people to hospital; injuries and cause are under investigation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
